News in brief: Beware counterfeit prostate cancer drugs

The MHRA has recalled a batch numbered 65520 of bicalutamide 50mg tablets (Casodex) that is used to treat prostate cancer, owing to counterfeit material supplied in French livery to the UK. Stock with the product license number PL 17901/0005 is not affected. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in